Safeplus International Holdings Ltd. (ACAI)

[sunspotter]

I found the news article at the link posted by b9molecule both touching and inspirational.

Thank heavens for the companies making such technology, and for the surgeons and others who make these advances possible.

Techisbest, it may be that the "CSS is a short-term, easy to implant device."

However, ever since it's been in Myotech's and now Biophan's hands, it hasn't been near a human being's chest cavity in all those years, whether it's easy to implant or not.

Given the relative ease of investigating medical devices (compared to drugs, at least), the demand which we all believe to be out there, and the countless millions that have been raised by Biophan (including a $1 million grant of taxpayers' money arranged with the help of Louise Slaughter a couple years back now)to pay for clinical research and human studies for the Myotech CSS device, I will confess to being completely baffled as to why it's taken so long to start human studies.

Anybody have a plausible explanation for that?

HCS Holdings, did you ask them about that during your call, assuming it's taken place already?